EPISODE · May 4, 2026 · 1 MIN
InspireMD's Q4 2025 Earnings: U.S. Launch Boosts Revenue
from The Daily News Now! Business
InspireMDs Q4 2025 earnings show a robust performance, with revenue surging 62% to $3.1 million, driven by a 74% growth in U.S. sales of their CGuard Prime stent. The company is rapidly expanding in the U.S., with a strong commercial team and positive feedback from physicians. They plan to enhance their delivery system, launch TCAR in 2026, and aim for significant revenue growth in 2026. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ddb99df6112f3d8c
NOW PLAYING
InspireMD's Q4 2025 Earnings: U.S. Launch Boosts Revenue
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m